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To learn more about nonimmune-mediated islet graft failure, we transplanted different preparations (preps)
of isolated human islets under the kidney capsule of streptozotocin (STZ)-diabetic nude mice. One month
after the implantation of 1,000 or 2,000 islets, grafts were harvested for morphological, immunohistochemi-
cal, and ultrastructural analysis. Only a single islet prep cured the diabetes out of all the recipients, while
the remaining preps showed only partial function after the implantation of 2,000 islets. Transplanted mice
showed high circulating proinsulin levels but, with the exclusion of those bearing curative grafts, relatively
low mature insulin levels. Engrafted β-cells showed positive carboxypeptidase E (CPE) and prohormone
convertase 1 (PC1) staining, while prohormone convertase 2 (PC2) was undetectable. In contrast, PC2 was
abundantly expressed by engrafted α-cells. Moreover, engrafted β-cells did not show evidence of replication,
and preapoptotic β-cells, with intra- and extracellular amyloid deposition, were detected with electron mi-
croscopy. Cell cycle inhibitors p16INK4, p21WAF1, and p27Kip1 were abundantly expressed in the islet grafts and
showed a predominant nuclear localization. In conclusion, diabetic nude mice transplanted with human islets
showed disproportionate hyperproinsulinemia and graft evidence of β-cell restricted PC2 depletion, amyloid
deposition and β-cell death, and lack of β-cell replication with nuclear translocation of p27Kip1 and p21WAF1
that together may contribute to delayed graft failure.
Key words: Islet transplantation; Proinsulin processing; Prohormone convertase 2 (PC2); p16INK4; p21WAF1;
p27Kip1; Athymic nude mice
INTRODUCTION after implantation, may account for these negative re-
sults (13,42,50). Recently, the “functional exhaustion”
of a chronically overstimulated marginal β-cell mass hasIslet transplantation can successfully restore long-
term exogenous insulin independence and improve gly- been implicated as a possible cause of graft failure (42).
We previously reported that the delayed (5 years post-cemic control in patients with type 1 diabetes, but the
number of patients who remain insulin independent de- transplantation) functional decline of an initially suc-
cessful islet graft is apparently unrelated to recurrenceclines progressively in 2–3 years (42). The numerous
hurdles encountered by the islets during isolation, and of autoimmunity, chronic rejection, and glucose toxicity
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(8). According to the “functional exhaustion” hypothe- was utilized for pancreatic digestion at a concentration
of 1.4 mg/ml. Experiments reported in this study weresis, before the recurrence of hyperglycemia, this patient
manifested a remarkable increase in circulating proinsu- performed with the islets obtained from 11 consecutive
preparations (preps) (donors age ranging from 44 to 60lin levels, indicative of ongoing overstimulation of trans-
planted β-cells (8). years) considered unsuitable for clinical transplantation
due to low islet yield.Islet transplantation into athymic nude mice allows
us to study the function and the morphology of the en-
Pretransplantation Characterizationgrafted β-cells in the absence of immune-mediated con-
founding factors (9,10). By using this model, it has been Transplantations were performed after an overnight
culture under standard conditions in Medium 199 (Eu-previously reported that transplanted human islets show
rapid amyloid deposition and β-cell death, which are roclone, Celbio, Milan, Italy), 10% FCS (Euroclone),
and penn/strep. Before transplantation, islet preps weretypical features of islet pathology in type 2 diabetes
(5,16,33,51). It is generally believed that adult human characterized for insulin content and islet cell death as
previously described (31).islets do not replicate after transplantation, but little in-
formation is available on this issue. Cell proliferation
Characterization of 5-Day Cultured Isletsrelies on the activation of cyclins and cyclin-dependent
kinases (CDKs), which act in G1 to initiate S phase and Aliquots of 2,000 unpicked islets from four isolations
were cultured for 5 days, under the conditions describedin G2 to initiate mitosis. To prevent uncontrolled prolif-
eration, cyclin–CDK complexes are precisely regulated above for measurements of β-cell mass, morphological
and ultrastructural analysis, and RNA extraction. The β-by two families of cell cycle inhibitors that block their
catalytic activity (44). The first class of inhibitors in- cell mass was measured on freshly isolated, overnight,
and 5-day cultured pelleted islet aliquots as previouslycludes INK4a proteins (such as p16INK4) that bind only
to CDK4-CDK6 kinases and not to cyclins and are described (9,10).
therefore specific for early G1 phase. The second family
Graft Recipientsof inhibitors is composed of CIP/Kip proteins (such as
p21WAF1 and p27Kip1) that inhibit all cyclins. Although Transplantations were performed in male Swiss nude
mice aged 5–7 weeks. These mice were made diabeticonly nuclear forms of CIP/Kip proteins should be proba-
bly considered as catalytic inhibitors of CDKs, p21WAF1 with a single IP injection of streptozotocin (180 mg/kg
of b.w.; Sigma, St. Louis, MO, USA) freshly dissolvedand p27Kip1 are also located in the cytoplasm where they
might fulfill different functions, including the modula- in citrate buffer at pH 4.5. Only mice with blood glucose
levels ≥ 19.5 mmol/L and failed native β-cell regenera-tion of apoptotic pathways (7,12,14).
To learn more about nonimmune-mediated causes of tion (unpublished observations) were used as graft recip-
ients.islet graft failure, we measured circulating insulin and
proinsulin levels and the residual graft β-cell mass in
Graft Composition, Transplantation, and OutcomeSTZ-diabetic nude mice transplanted with human islets.
Our prediction that circulating proinsulin to insulin ra- Grafts were composed of unpicked islet aliquots (pu-
rity 60–80% by dithizone staining) differing in islettios would correlate inversely with the outcome of the
graft and the residual β-cell mass was confirmed only in number (1,000 vs. 2,000) and transplanted under the left
kidney capsule as previously described in detail (10).part. Notably, transplanted β-cells did not show prohor-
mone convertase 2 (PC2) immunoreactivity, which, con- After transplantation, random (nonfasted) blood glucose
levels were measured twice weekly (10). Fully Effectiveversely, was abundant in the α-cells. Ultrastructurally,
the grafts showed degranulated and preapoptotic β-cells Prep (FEP) was the only one in which 1,000 islets were
sufficient to restore recipients’ normoglycemia; Partlywith intra- and extracellular deposition of islet amyloid
pancreatic polypeptide (IAPP) fibrils. Moreover, trans- Effective Preps (PEPs) were those in which 2,000 islets
reduced recipients’ hyperglycemia only in part. Oneplanted islets showed negative Ki67 staining and abun-
dant expression of p16INK4, thereby confirming the lack month after transplantation, after 6 h of fasting, mice
were bled and euthanized and grafts quickly removed.of replication of engrafted β- and α-cells. Cell cycle in-
hibitors p21WAF1 and p27Kip1 were expressed in the islets Recipients’ sera were stored at −20°C until assayed for
human insulin by MEIA (IMX System, Abbott Labora-grafts, which showed selective nuclear localization.
tories, IL, USA) and for proinsulin by ELISA (Dako,
MATERIALS AND METHODS Cambridgeshire, UK). For comparison purposes, insulin
Human Islet Isolation and proinsulin were also measured in the sera of 10 non-
diabetic subjects. Insulin and proinsulin were expressedIslets were isolated using the Ricordi method (39).
Liberase (Roche Pharmaceuticals, Indianapolis, USA) in pmol/L and circulating proinsulin to insulin ratios
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were calculated as percent proinsulin over insulin con- (32) and to Lan et al. (26) and/or using serial consecu-
tive sections. Confocal microscopy was performed ascentrations.
previously described (15) as well as ultrastructural ex-β-Cell Mass in the Harvested Grafts amination, electron microscopy, and immunocytochem-
istry (16). For the immunogold technique, samples wereGrafts were peeled off of the kidney, weighed, em-
bedded in OCT, and snap frozen. Grafts were then sec- incubated with anti-IAPP antibody (Peninsula Labora-
tories, Belmont, CA; at 1:500) and then with 1:50 gold-tioned with a cryostat and the β-cell mass of insulin-
stained sections was measured using a morphometric tagged goat anti-rabbit (EY Laboratories, San Mateo,
CA, USA) (16).approach as previously described (17) and expressed in
milligrams.
Immunofluorescence Stainings
Morphology, Immunohistochemistry,
After microwave antigen retrieval, 5-µm-thick sec-
and Electron Microscopy
tions from normal pancreases, 5-day cultured islets, and
Two surgical and three autopsic normal pancreases, islet grafts harvested from transplanted mice were incu-
four cases of 5-day cultured islets, and six cases of 2,000 bated with primary antibodies (PC1, PC2, CPE, p27Kip2)
islet grafts harvested from mice either cured or not cured overnight at 4°C followed by 2-h incubation with a bio-
by transplantation were fixed in buffered formalin for tin-conjugated secondary antibody and fluorescein iso-
24 h and routinely processed for paraffin embedding. thiocyanate (FITC)-conjugated streptavidin. To identify
After microwave antigen retrieval, 5-µm-thick sections α- and β-cells, sections were subsequently double
were incubated with primary antibodies at 4°C for stained with anti-hormone antibodies (glucagon, insulin,
18–20 h before undergoing the avidin-biotin complex and proinsulin) for 2 h at room temperature, followed(ABC) procedure (22). Sections were then immersed in by the appropriate secondary antibodies. Secondary anti-
0.03% 3,3-diaminobenzidine tetrahydrochloride and bodies were from Jackson Laboratories. Confocal mi-
counterstained with Harris’ hematoxylin. The following croscopy was performed as previously described (15);
antibodies and antisera were used: anti-synaptophysin to minimize the bleed through, sequential sections were(BioGenex Laboratories, San Ramon, CA, USA; mono- taken with low iris diameter.
clonal at 1:100 dilution), anti-glucagon (Milab, Malmo, To evaluate the percentage of insulin- or glucagon-
Sweden; polyclonal at 1:1250 dilution), anti-insulin positive cells with nuclear p27Kip1 staining, sections de-(BioGenex Laboratories, San Ramon, CA, USA; mono- rived from three different cases of transplanted mice
clonal at 1:200), anti-proinsulin (Novo Nordisk, Hiller?- were triple stained with p27Kip1, insulin, and glucagon.
dgarde, Copenhagen, Denmark; monoclonal at 1:200), Transplanted islets were imaged, and the number of β-
anti-prohormone convertase 1 (ABC Affinity Bioreagent, or α-cells with nuclear p27Kip1 were manually counted.
Golden, CO, USA; polyclonal at 1:50), anti-prohormone At least 150 insulin-positive and glucagon-positive cells
convertase 2 (NOVUS Biologicals, Littletown, CO, for each case were counted. Data are expressed as a
USA; polyclonal at 1:50), anti-carboxypeptidase E (BD mean ± SE. Comparisons between the two groups were
Transduction, Franklin Lakes, NJ, USA; monoclonal at performed by Student’s dependent t-test, and p < 0.05
1:50), anti-p27Kip1 (BD Transduction, Franklin Lakes, was considered statistically significant.
NJ, USA; monoclonal at 1:200), anti-p16INK4 (BD Phar-
mingen, San Diego, CA, USA; monoclonal at 1:200), p16INK4 and p27Kip1 Semiquantitative RT-PCR
anti-p21WAF1 (Oncogene Research, Nottingham, UK;
Total RNA was extracted from overnight- and 5-daymonoclonal at 1:100), anti-bcl2 (Dako, Carpintera, CA,
cultured islets using the RNAfast method (MolecularUSA; monoclonal at 1:40), anti-caspase cleavage prod-
Systems, San Diego, CA, USA). Semiquantitative RT-uct of cytokeratin 18 clone M30 (Hoffmann-LaRoche,
PCR was performed as previously described (15). Se-Basel, SW; monoclonal at 1:100), and anti-Ki67 (Dako,
quences of the oligonucleotides used in the RT-PCRCarpintera, CA, USA; monoclonal at 1:100). Apoptag
analysis for p16INK4 were as follows: forward 5′-cccgctttstaining was performed as suggested by the manufac-
cgtagttttcat-3′, reverse 5′-ttatttgagctttggttctg;-3′ and forturer (Chemicon International, Tamecula, CA, USA).
p27Kip1: forward 5′-agatgtcaaacgtgcgagtg-3′; reverse 5′-The percentage of positive cells for various antibodies
tctctgcagtgcttctccaa-3′.employed was evaluated by counting at least 200 cells
for each case (five of normal pancreas, four of cultured
Statistical Analysisislets, and six of transplanted islets under the kidney
capsule). In the figures and tables, n indicates the number of
experiments or animals; data are expressed as mean ±Colocalization studies were performed with double-
label immunostaining according to Mason and Sammons SE. Comparisons between groups were performed by
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factorial two-way analysis of variance (ANOVA), and 5 (p < 0.02 vs. day 0, n = 4). Mature insulin levels were
significantly higher in the FEP than in PEP recipientsp < 0.05 was considered statistically significant.
while proinsulin levels were similar and remarkably
RESULTS high in both the FEP and PEP recipients (Table 2). Due
to the higher insulin levels, circulating proinsulin to in-Metabolic Outcome of the Grafts
sulin ratios were significantly lower in the FEP than inTransplantation of 1,000 islets did not induce any re-
the PEP recipients. Mice transplanted with 1,000 FEPduction of blood glucose levels in five of the seven
islets showed a proinsulin to insulin ratio of 146%,preps; a small significant decrease and the reestablish-
which was significantly higher than the 45% detected inment of normoglycemia were observed only with islets
the recipients of 2,000 islets (p < 0.02). For comparisonof preps F and G, respectively (Table 1). Transplantation
purposes, the mean proinsulin to insulin ratio detectedof 2,000 islets reduced glycemic levels in all the recipi-
with our assays in the sera of 10 nondiabetic subjectsents, but normoglycemia was achieved only with islets
was of 3.7 ± 1.2%.of prep G. Therefore, six out of the seven preps were
considered Partly Effective Preps (PEPs, preps A–F),
Expression of CPE, PC1, and PC2 in Native, Cultured,
while there was only one Fully Effective Prep (FEP,
and Transplanted Isletsprep G).
Native islets, islets cultured for 5 days, and isletBefore the implantation, islet preps were similar in
grafts showed positive CPE staining in both insulin-terms of viability (data not shown), while insulin content
positive and insulin-negative cells (Fig. 1A–C). In con-was about fivefold higher in the FEP than in the PEPs
trast, PC1 and PC2 were undetectable in native (Fig. 1D,(2,400 µU vs. 455 ± 60 µU of insulin/µg of total protein,
G) and cultured islets (Fig. 1E, H). In the islet grafts,n = 6). One month after the implantation, pooled gly-
PC1 staining was positive in insulin-positive and insu-cemic levels of the recipients of 1,000 and 2,000 islets
lin-negative cells (Fig. 1F). Conversely, strong PC2 po-from PEPs were 25.0 ± 0.6 and 19.4 ± 0.8 mmol/L, re-
sitivity was exclusively localized in insulin negativespectively, p < 0.05 (Table 2). Conversely, mice trans-
cells (Fig. 1I). Because overstimulated β-cells may haveplanted with the FEP were all normoglycemic and the
few mature insulin granules, sections of islet grafts wererecipients of 1,000 and 2,000 islets showed similar
also double stained with antibodies against proinsulin orblood glucose levels (5.8 ± 0.2 and 5.5 ± 0.2, respec-
glucagon and PC1 or PC2 (Fig. 2). While PC1 was de-tively) (Table 2).
tected in both proinsulin- and glucagon-positive cells
Graft β-Cell Mass and Secretory Parameters (Fig. 2C, F), PC2 was exclusively localized in glucagon-
in Graft Recipients positive β-cells (Fig. 2I, L).
β-Cell mass of 1,000 and 2,000 islet grafts performed
Morphology and Ultrastructure of Culturedwith PEPs was 0.6 ± 0.01 and 1.18 ± 0.1 mg, respec-
and Transplanted Isletstively (p < 0.05), while that with the FEP was 1.6 ± 0.2
and 2.6 ± 0.5 mg, respectively (p < 0.05) (Table 2). For Morphology of cultured islets showed β-cells with
degenerative features such as loss of cell aggregationcomparison in vitro, the β-cell mass of 2,000 islets ali-
quots decreased from 5.1 ± 0.9 at day 0 to 3.4 ± 0.8 at and reduction of cell size with hyperchromic nuclei sug-
gestive of initial apoptosis. In the islets grafts, we de-day 1 (p < 0.05 vs. day 0, n = 4) to 2.8 ± 0.4 mg at day
Table 1. Metabolic Outcome of the Grafts: Glycemic Levels Measured Before
and 1 Month After Transplantation of 1,000 or 2,000 Islets Under the Kidney Capsule
of STZ-Diabetic Nude Mice
1,000-Islet Grafts 2,000-Islet Grafts
Prep. Pre-Tx Post-Tx n p Pre-Tx Post-Tx n p
A 27.5 ± 1 22.2 ± 2 8 NS 30.1 ± 1 25.6 ± 1 6 <0.05
B 33.0 ± 0.5 33.1 ± 0.5 9 NS 32.5 ± 1 16.9 ± 2 9 <0.02
C 27.4 ± 1 18.3 ± 7 4 NS 26.1 ± 3 14.5 ± 3 4 <0.05
D 28.2 ± 2 22.8 ± 3 5 NS 30.6 ± 1 20.4 ± 3 5 <0.05
E 22.2 ± 1 17.1 ± 2 3 NS 30.1 ± 2 20.2 ± 1 3 <0.05
F 32.4 ± 0.5 22.4 ± 0.5 3 <0.02 33.3 ± 1 14.9 ± 3 3 <0.02
G 27.1 ± 1 5.8 ± 0.2 8 <0.001 25.2 ± 0.5 5.5 ± 0.2 6 <0.001
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Table 2. Graft β-Cell Mass, Blood Glucose, Insulin and Proinsulin Levels, and Proinsulin/Insulin Ratios 1 Month
After Transplantation of 1,000 and 2,000 Islets from PEPs and FEP Into STZ-Diabetic Mice
PEPs 1,000 Islets PEPs 2,000 Islets p FEP 1,000 Islets FEP 2,000 Islets p
Graft β-cell mass (mg) 0.06 ± 0.01 1.18 ± 0.1 p < 0.05 1.6 ± 0.2* 2.6 ± 0.5* NS
(n = 32) (n = 30) (n = 8) (n = 6)
Blood glucose (mmol/L) 25.0 ± 0.6 19.4 ± 0.8 p < 0.05 5.8 ± 0.2† 5.5 ± 0.2† NS
(n = 32) (n = 30) (n = 8) (n = 6)
Insulin (pmol/L) 20 ± 3 28 ± 6 NS 64 ± 12 118 ± 32 NS
(n = 23) (n = 25) (n = 8) (n = 6)
Proinsulin (pmol/L) 43 ± 5 72 ± 7 NS 93 ± 12* 53 ± 5* NS
(n = 23) (n = 25) (n = 8) (n = 6)
Proinsulin/insulin ratio (%) 217 ± 36 251 ± 72 NS 146 ± 36‡ 45 ± 11† p < 0.02
(n = 23) (n = 25) (n = 8) (n = 6)
*p < 0.01 versus PEPs.
†p < 0.001 versus PEPs.
‡p < 0.05 versus PEPs.
tected degenerated and preapoptotic β-cells in both eug- p16INK4 was expressed by native, cultured, and trans-
planted islets (Fig. 5D, I, N) and localized in the nucleilycemic and diabetic mice [blood glucose 7.3 ± 1.5 (n =
3) vs. 21.6 ± 3.4 mmol/L (n = 3); p < 0.02]. Quantifica- and cytoplasm (Fig. 5N, inset). p27Kip1 (Fig. 5A, F, K)
showed a different pattern of expression: in native isletstion of insulin- and glucagon-positive cells showed a
reduction in β-cell percent ratio from normal native the majority of the cells showed cytoplasmic and nuclear
staining (Fig. 5A), while p27Kip1 was undetectable in cul-(74.8% of total islet cells) to cultured (35%) to trans-
planted islets (7.1%). By contrast, the α-cell percent ra- tured islets (Fig. 5F). Strong p27Kip1 immunoreactivity
resumed in transplanted islets but was exclusively local-tio increased from native (35%) to cultured (47%) to
transplanted islets (95.5%) (Table 3). Electron micros- ized to the nucleus (Fig. 5K, inset). Percentage of
p27Kip1-positive cells decreased from native (72%) tocopy of the islet grafts confirmed the presence of
sparsely granulated β-cells with degenerative features cultured islets (9.6%) but increased after transplantation
(55%) (Table 3). Culture-induced p27Kip1 reduction wassuch as pyknotic nuclei and dilated cysternae of the en-
doplasmic reticulum. Densely packed IAPP-positive fi- confirmed by RT-PCR, where 5-day cultured islets
showed a 40% reduction of p27Kip1 mRNA as comparedbrillar deposits were observed in the reticulum cysternae
and in the extracellular spaces (Fig. 3A, B). Ultrastruc- to the overnight cultured. Conversely, p16INK4 mRNA re-
mained stable in overnight and 5-day cultured isletsturally, engrafted α-cells appeared wealthy and well
granulated (data not shown). (data not shown). Similar to p27Kip1, native islets showed
positive p21WAF1 staining of both nuclei and cytoplasm;
Expression of Protein Involved in Apoptosis p21WAF1 was undetectable in cultured islets and resumed
and Cell Cycle Control in transplanted islets where it was localized exclusively
in the nuclei (not shown). Percentage of p21WAF1-positiveStaining with M30 and apoptag showed massive apo-
cells was 16 in native islets and 23 in transplanted isletsptosis in cultured islets (Fig. 4A) that was limited to the
(Table 3). Triple label immunostaining with antibodiesβ-cells (Fig. 4C–F). The mean percentage of apoptotic
against p27Kip1, insulin, and glucagon showed that p27Kip1cells, evaluated by counting at least 200 cells, was 22%,
was preferentially localized in the nuclei of the β-cellsranging from 10% to 51%. Conversely, transplanted is-
and, at a lower extent, also in the α-cells (Fig. 6). Thelets did not show positive M30 and apoptag staining in
mean percentage of insulin-positive and glucagon-posi-all six cases examined (Fig. 4B). Antiapoptotic bcl2 pro-
tive cells with nuclear p27Kip1 staining was 63.24 ±tein was negative in endocrine cells of both cultured and
4.91% and 21.35 ± 7.98%, respectively (p < 0.05).transplanted islets, while positive in contaminant trans-
planted ducts (data not shown). Ki67, a marker of cell
DISCUSSIONproliferation (24,43), was negative in both cultured and
transplanted islets, indicating the absence of active cell Islet transplantation can successfully restore exoge-
nous insulin independence in patients with type 1 diabe-proliferation (Fig. 4G–I). Rare Ki67-positive cells were
detected in contaminant ducts but not in the endocrine tes; however, the function of the graft declines over time
and insulin therapy must be eventually resumed (42).component of the grafts (Fig. 4H, I). Cell cycle inhibitor
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Figure 1. PC1, PC2, and CPE expression in autopsic pancreas and in cultured and transplanted islets. Normal native (A, D, G), 5-
day cultured (B, E, H), and transplanted islets (C, F, I) were double stained for insulin (in red), CPE (A–C), PC1 (D–F), and PC2
(G–I) (in green). The yellow staining in the merge indicates colocalization. Images were obtained using the confocal microscope.
CPE was highly expressed by insulin-positive cells in either native, cultured, or transplanted islets. Note that both PC1 and PC2
were negative in cultured islets but positive in islet grafts. In the latter, PC1 was present in both insulin-positive (yellow/orange
staining in F) and insulin-negative cells (red staining in F), while PC2 was detected exclusively in insulin-negative cells. The
absence of PC1/2 staining in the native islets may be ascribed to the long period of tissue ischemia (postmortem sample) and the
different fixation protocol.
The “functional exhaustion” of a marginal, chronically nonimmune-mediated islet graft failure, we transplanted
human islets into STZ-diabetic nude mice. The outcomeoverstimulated, β-cell mass has been indicated as a
likely explanation, and the increase in circulating proin- of our grafts was considerably poor because 1,000 islets
restored normoglycemia only in one out of the sevensulin levels detected before the return of the hyperglyce-
mia supports this hypothesis (8). series of transplantations shown in Table 1. Concerns
about the quality of the islet preps is confirmed by aTo better understand the mechanisms responsible for
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Figure 2. PC1 and PC2 staining in transplanted islets. Islet grafts were double stained for proinsulin (B, H) or glucagon (E, K) (in
red) and for PC1 (A, D) or PC2 (G, J) (in green). Note that PC1 was expressed by both proinsulin-positive cells (C) and by the
glucagon-positive cells (F). In contrast, PC2 was absent in proinsulin-positive cells (I) while abundantly expressed in glucagon-
positive cells as shown by the yellow staining in the merge (L). These results were representative of the staining performed in
three different grafts.
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Table 3. Percentage of Insulin-, Glucagon-, p27Kip1-, with 1,000 islets (Table 2). However, the recipients of
and p21WAF1-Positive Cells in Native Pancreases, in 5-Day curative grafts that returned to normoglycemia immedi-
Cultured Islets, and in Transplanted Islets 1 Month ately after the transplantation (data not shown) still
After Transplantation showed severe disproportionate hyperproinsulinemia 1
month later (Table 2). The presence of disproportionateInsulin Glucagon p27Kip1 p21WAF1
hyperproinsulinemia in long-standing normoglycemic
Native islets 75% 35% 72% 16% mice implies intrinsic defects in insulin processing by
5-Day cultured islets 35% 47% 10% not detected transplanted β-cells.
Transplanted islets 7% 95% 55% 23% The expression of the enzymes that convert proinsu-
lin into insulin (PC1, PC2, and CPE) was different inThe percentage of positive cells was evaluated by counting at least
native, cultured, and transplanted islets. CPE was abun-200 cells for each case (five of normal native pancreas, four of cul-
tured islets, and six of transplanted islets under the kidney capsule). dantly expressed by either native, cultured, or trans-
planted islets. Conversely, PC1 and PC2 were clearly
detectable only in the islet grafts. This does not mean
that PC1 and PC2 are not expressed by cultured islets.previous paper where 1,000 human islets restored nor-
moglycemia in only 23% of the recipient mice (1). In Perhaps the culture condition may interfere with these
stainings. CPE staining was intense in islet grafts (Fig.another study, 33% of all islet preps failed to restore
normoglycemia with the implantation of 2,000 islets 1C) while PC1 was scant in both insulin- and proinsulin-
positive cells (Fig. 1F, Fig. 2C) and abundant in the α-(36). Better outcomes have also been reported, but pre-
transplantation glycemic levels were not reported in that cells (Fig. 2F). Staining for PC2 was more intense than
that of PC1 in islet grafts but localized exclusively instudy (46). The relationship between the severity of pre-
transplantation glycemic levels and the outcome of hu- the α-cells (Fig. 2L). Selective PC2 downregulation has
been reported in the islets of diabetic Goto-Kakizakiman islet implants has not been addressed in mice.
Blood glucose >300 mg/dl may be sufficient to consider rats, which do not show hyperproinsulinemia (19).
Therefore, the combination of PC2 and PC1 deficiency,a mouse diabetic (23), but reestablishment of normogly-
cemia in mice with mild hyperglycemia is presumably as we observed in transplanted β-cells, may be necessary
to determine the abnormally high proinsulin levels de-easier than in mice with severe hyperglycemia (500–600
mg/dl), such as those utilized in this study. tected in our recipients.
Ultrastructural analysis of the islet grafts showed de-We here confirmed previous reports showing that the
β-cell mass of human islet grafts decreases over time, granulated and preapoptotic β-cells with intra- and ex-
tracellular deposition of IAPP-positive fibrils (Fig. 3).while endocrine non-β-cells remain quantitatively stable
(8,9,16) (Fig. 5L, M). Islet transplantation is followed Human IAPP (hIAPP) is the major constituent of pan-
creatic amyloid deposits found in type 2 diabetic sub-by a dramatic remodeling process that is accompanied
by massive β-cell death (11). Treatment with exogenous jects (5) and insulinomas (35). hIAPP is synthesized as
a propeptide (prohIAPP) that colocalizes with insulininsulin partially prevents β-cell graft death (11), sug-
gesting that hyperglycemia-induced β-cell overstimula- granules where it is converted to IAPP by the same en-
dopeptidases (PC1/2 and CPE) that convert proinsulintion may be implicated in delayed graft failure. The ab-
normality most clearly linked to β-cell overstimulation into insulin (3,20,30). A particular proIAPP cleavage
product has the potential for “seeding” amyloid deposi-is disproportionate hyperproinsulinemia (6,28,34,40,41),
which is absent in patients with a combined pancreatic– tion, a process hindered by insulin but much less effi-
ciently by proinsulin (52). In overstimulated β-cells, si-kidney graft (2). In contrast, we observed severe dispro-
portionate hyperproinsulinemia in mice bearing human multaneous depletion of insulin stores and/or defective
proIAPP processing may determine a favorable condi-islet grafts, regardless of their function (Table 2). This
was not unexpected because isolated human islets may tion for the precipitation of fibrillogenic proIAPP prod-
ucts (37) leading to cell death (27,38). The lack of PC2also secrete abnormally high proinsulin amounts in vitro
(4,15). Circulating proinsulin to insulin ratios of mice in transplanted β-cells is particularly relevant in this re-
gard because impaired NH2-terminal processing ofbearing curative grafts (FEP recipients) were lower than
those of PEPs recipients (Table 2). The higher residual hIAPP, as occurs in absence of PC2, determines amyloid
formation and cell death in vitro (29). Studies in miceβ-cell mass found in curative grafts might explain this
difference, as β-cell overstimulation was presumably overexpressing hIAPP further support that β-cell over-
stimulation can induce islet amyloidosis (21,45,48) andlower in FEP than in PEP grafts. Less severe β-cell
overstimulation may also explain why, in curative grafts, that transplantation is another amyloidogenic procedure
(49).proinsulin to insulin ratios were significantly lower in
the recipients of 2,000 islets than in mice transplanted As shown by M30 and apoptag staining, and in agree-
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Figure 3. Amyloid deposition in transplanted β-cells. (A) In transplanted islets, densely packed fibrillar deposits are found in both
β-cells (right bottom and right top) and in the extracellular space. (B) Corresponds to the superior rectangle of (A); fibrillar material
is present in reticulum cysternae among typical secretory granules, characterized by a crystalline central core surrounded by a clear
halo. (C) Corresponds to the inferior rectangle of (A); fibrillar material is present in the extracellular space (asterisk), close to a β-
cell, containing typical secretory granules, present in the right bottom. (D) Immunogold technique demonstrates that fibrillar depos-
its are intensely IAPP positive, as better shown in the inset.
ment with previous data (15), we observed massive β- lets (Table 3), where p16INK4 was expressed in both nu-
clei and cytoplasm (Fig. 5I, N). Noteworthy is that thecell apoptosis in human islets cultured in vitro (Fig. 4A).
M30 was negative in the islet grafts (Fig. 4B), but the expression pattern of p16INK4, p21WAF1, and p27Kip1 was
similar in grafts harvested from either normoglycemicoccurrence of sporadic β-cell apoptosis was detected
with electron microscopy. Negative Ki67 staining con- or hyperglycemic mice (not shown). It has been recently
shown that p16INK4 increases with age, and limits β-cellfirmed lack of β- and α-cell replication in both cultured
and transplanted islets (Fig. 4 G, H), and indicates that regenerative potential of rodent islets (25). Therefore,
abundant p16INK4 expression in stabilized grafts may ac-the inverted β-/α-cell ratio of human islet grafts is ex-
clusively due to the loss of the β-cells. The cell cycle count for a lack of replication of the engrafted β-cells.
Interestingly, p27Kip1 and p21WAF1 were positive in theinhibitor p16INK4 was positive in both the β- and α-cells
and more abundant than in the exocrine pancreas. This cytoplasm of native islets, but were negative in cultured
islets when several β-cells undergo apoptosis. Downreg-was particularly evident in cultured and transplanted is-
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Figure 4. Apoptosis and replication in cultured and transplanted islets. M30 immunoreactivity in 5-day cultured islets (A) indicated
apoptosis, which was not the case for transplanted islets (B). Apoptag staining confirmed M30 results. In serial sections of 5-day
cultured islets, apoptag staining (C) colocalizes with insulin (D) (arrows indicated some of the cells with colocalization). On the
contrary, in 5-day cultured islets glucagon-producing β-cells (E) did not show apoptosis, as indicated by negative staining for M30
(F). Cultured islets were negative for Ki67 (G), while rare Ki67-positive cells were present in the islet grafts (H). However, these
cells were not of endocrine origin as shown by the negative synaptophysin staining (arrows indicated Ki67-positive, synaptophysin-
negative cells) (I).
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Figure 5. Cell cycle inhibitory proteins expression and subcellular localization in autopsic pancreas, and in cultured and transplanted islets. In normal native islets the majority
of the cells were p27Kip1 positive, showing both cytoplasmic and nuclear staining (A). In 5-day cultured islets, p27Kip1 was completely absent (E), while a strong p27Kip1 positivity
was detected in stabilized grafts (I) where p27Kip1 was exclusively localized to the nucleus (inset). Conversely, p16INK4 was expressed by the endocrine cells of normal native
(D), cultured (H), and transplanted islets (N). This p16INK4 was localized in both the cytoplasm and nuclei (inset). Note that p16INK4 was almost absent in the contaminant exocrine
tissue (N). A progressive reduction in the β-cells (B, F, L) and a dramatic increase in the relative α-cells numbers (C, G, M) occurs from native to cultured to transplanted
islets (original magnification 400×, inset 1,000×).
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Figure 6. Localization of p27Kip1 with confocal microscopy in β- and α-cells of cultured and transplanted islets. Triple label
immunostaining with antibodies against p27Kip1 (in green), insulin (in red), and glucagon (in blue) shows that p27Kip1 is preferentially
localized in the nuclei of the β-cells and, at a lower extent, also in the α-cells. Scale bar: 10 µm.
startup funds from UTHSCSA (F.F.). A.M.D. is grateful toulation of p27Kip1 in cultured islets was confirmed by
Prof. Emanuele Bosi for the continuous support.RT-PCR. Transplanted islets returned to show positive
p27Kip1 and p21WAF1 staining, which, however, were en-
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